Syn2bio (WAR:S2B) EV-to-FCF: (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:S2B Syn2bio SA WAR:S2B
11 GF Score
Price zł81.40
! 2 Warning Signs
View Full Analysis

What is Syn2bio EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Syn2bio's Enterprise Value is zł703.98 Mil. Syn2bio does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025. Therefore, GuruFocus does not calculate Syn2bio's EV-to-FCF at this moment.

The historical rank and industry rank for Syn2bio's EV-to-FCF or its related term are showing as below:

WAR:S2B' s EV-to-FCF Range Over the Past 10 Years
Min: -32.76   Med: 0   Max: 0
Current: -32.76
WAR:S2B's EV-to-FCF is ranked worse than
100% of 335 companies
in the Biotechnology industry
Industry Median: 15.34 vs WAR:S2B: -32.76

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-14), Syn2bio's stock price is zł81.40. Syn2bio does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025. Therefore, GuruFocus does not calculate Syn2bio's PE Ratio (TTM) at this moment.

Syn2bio  (WAR:S2B) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Syn2bio's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=81.40/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Syn2bio EV-to-FCF Related Terms

Syn2bio EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Syn2bio's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syn2bio EV-to-FCF Chart

Syn2bio Annual Data
Trend Sep23 Sep24 Sep25
EV-to-FCF
0.00 0.00 0.00

Syn2bio Semi-Annual Data
Sep23 Sep24 Sep25
EV-to-FCF 0.00 0.00 0.00

WAR:S2B vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, Syn2bio's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syn2bio EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syn2bio's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Syn2bio's EV-to-FCF falls into.


WAR:S2B
11GF Score
Syn2bio SA WAR:S2B
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syn2bio EV-to-FCF Calculation

Syn2bio's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=703.978/
=

Syn2bio Business Description

Address ul. Jozefa Piusa Dziekonskiego 3, Warszawa, POL, 00-728
Syn2bio SA is a Polish biotech company that develops radiopharmaceuticals. It specializes in developing a cardiac biomarker for diagnosing heart conditions like coronary artery disease through myocardial perfusion imaging. The company's flagship product is the SYN2 cardiotracer. It is applied in the detection of perfusion disorders, evaluation of patients after myocardial infarction or with ischemic heart disease, and assessment of atherosclerotic changes in coronary arteries.
11GF Score

Get the complete analysis for WAR:S2B

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł81.40
Price